ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2022 American Transplant Congress

    Treatment Modality and Outcomes of Antibody-Mediated Rejection in Pediatric Kidney Transplant Recipients: The PARAMOUr Study

    R. Engen1, A. Jain2, N. Hayde3, A. Mansuri4, M. Kallash5, S. McEwen6, R. Garro7, C. Peterson8, R. Zahr9, L. Harshman10, D. Puliyanda11, S. Solomon12, K. Twombley13, I. Ashoor14

    1Pediatrics, University of Wisconsin Madison, Madison, WI, 2Wayne State University, Detroit, MI, 3Albert Einstein College of Medicine, New York, NY, 4Augusta University, Augusta, GA, 5The Ohio State University, Columbus, OH, 6University of Minnesota, Minneapolis, MN, 7Emory University, Atlanta, GA, 8University of Utah Health, Salt Lake City, UT, 9The University of Tennessee Health Science Center, Memphis, TN, 10University of Iowa, Iowa City, IA, 11Cedars-Sinai Medical Center, Los Angeles, CA, 12New York Medical College, Valhalla, NY, 13Medical University of South Carolina, Charleston, SC, 14Louisiana State University, New Orleans, LA

    *Purpose: Antibody-mediated rejection (AMR) is the leading cause of graft failure in kidney transplantation, but evidence for effective treatments is limited.*Methods: PARAMOUr is a retrospective…
  • 2022 American Transplant Congress

    Generation and Functional Characterization of Bio-Engineered Livers for Heterotopic Implantation in Porcine Model of Acute Liver Failure

    A. A. Katane1, B. P. Amiot2, A. R. Stumbras1, A. Mendenhall1, N. R. Palumbo1, A. C. Donepudi1, J. J. Ross1, S. L. Nyberg3

    1Miromatrix Medical Inc, Eden Prairie, MN, 2Department of Surgery, Mayo Clinic, Rochester, MN, 3William J. von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN

    *Purpose: Liver transplantation has shown to be an effective therapy for the end-stage liver diseases (ESLD). However, as donor organ shortages increase, organ engineering technology…
  • 2022 American Transplant Congress

    Final Flow and Resistance During Cold Pulsatile Perfusion Preservation Do Have Value in Prediction of Deceased Donor Graft Survival After Adjusting for KDPI

    D. S. Keith, E. Lessmann

    Kidney Transplant, Sacred Heart Hospital, Pensacola, FL

    *Purpose: To determine whether cold pulsatile perfusion preservation (CPPP) parameters of flow and resistance provide additional data regarding deceased donor kidney graft survival after adjusting…
  • 2022 American Transplant Congress

    Early Experience with OmniGraf® Biomarker Surveillance in Kidney Transplant Patients in the First-Year Post-Transplant and Beyond

    V. Paramasivam1, W. Ally2, B. Sivakumar3, B. Greco1, M. Germain1

    1Baystate Medical Center, Springfield, MA, 2Eurofins Transplant Genomics, Framingham, MA, 3Dartmouth College, Hanover, NH

    *Purpose: Non-invasive rejection biomarkers continue to evolve with recent data supporting the use of combined gene expression and donor derived cell-free DNA (dd-cfDNA) in kidney…
  • 2022 American Transplant Congress

    The US Kidney Allocation System Should Not Allocate En Bloc Kidneys from Deceased Donors < 18 Kg as Equivalent to Top 20% KDPI Single Kidneys

    W. F. Parker1, A. Gallo2, L. Ross1

    1University of Chicago, Chicago, IL, 2Stanford University, Palo Alto, CA

    *Purpose: In December 2020, the US Kidney Allocation System (KAS) revised the allocation rules for deceased donors under 18 kg, stating that both kidneys must…
  • 2022 American Transplant Congress

    Variation in Donor Liver Rejection Rates for Donor Quality Among US Transplant Centers

    M. Anderson1, T. Gilbert2, M. Englesbe1, S. Waits1

    1Michigan Medicine Transplant Center, Ann Arbor, MI, 2University of Michigan Medical School, Ann Arbor, MI

    *Purpose: Optimal utilization of all viable donor livers is a public health imperative. As no standardized criteria exist for assessment of donor quality, differential utilization…
  • 2022 American Transplant Congress

    The Use of Frailty Assessment to Determine Fitness for Renal Transplant in a Veteran Dialysis Patient Population

    M. Samra1, A. Wadhwa1, T. Markossian2, R. Lopez-Soler3

    1Medicine, Edward Hine Jr., VA Medical Center, Hines, IL, 2Edward Hine Jr., VA Medical Center, Hines, IL, 3Surgery, Edward Hines VA Jr.,VA Medical Center, Chicago, IL

    *Purpose: Frailty is a medical syndrome characterized by reduced physiologic function and strength. It is associated with an increased risk of mortality, hospital readmission and…
  • 2022 American Transplant Congress

    Impact of Belatacept Conversion on Renal Function and Donor Specific Antibodies in Renal Transplant Recipients

    E. R. Brown, K. Cunningham, K. Paplaczyk, C. Dagostino, C. Kane, A. Shetty

    Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Although associated with nephrotoxicity, calcineurin inhibitors (CNI) have historically been the cornerstone of immunosuppression. Belatacept, a co-stimulation blocker, is FDA-approved for de novo use…
  • 2022 American Transplant Congress

    Impact of Target Tacrolimus Levels on BK Polyomavirus DNAemia and Allograft Rejection Among Pediatric Kidney Transplant Recipients

    H. Huang1, P. Winterberg1, R. George1, A. Serluco2, R. Liverman2, I. Yildirim3, R. Garro1

    1Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA, 2Children's Healthcare of Atlanta, Atlanta, GA, 3Yale University School of Medicine, New Haven, CT

    *Purpose: BK Polyomavirus (BK) DNAemia is a serious and common infectious complication after kidney transplant (KT). We evaluated the impact of targeting lower tacrolimus levels…
  • 2022 American Transplant Congress

    Non-Invasive Assessment of Hepatic Ischemia-Reperfusion Injury Using Dynamic Contrast Enhanced-MRI and T2 Mapping

    O. C. Rodriguez1, J. R. Liggett2, J. Kang2, K. Loh2, Y. Lee1, N. Sang1, B. He1, Y. Cui2, K. Oza2, D. Kwon3, B. Kallakury3, T. Fishbein2, W. Cui2, K. Khan2, C. Albanese1, A. Kroemer2

    1Lombardi Comprehensive Cancer Center and the Center for Translational Imaging, Georgetown University Medical Center, Washington, DC, 2MedStar Georgetown Transplant Institute, Washington, DC, 3Pathology, MedStar Georgetown University Hospital, Washington, DC

    *Purpose: Hepatic ischemia-reperfusion injury (IRI) is a consequence of liver transplantation and hepatectomy that varies in severity and clinical significance. The diagnosis is made based…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 1683
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences